Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Gantenerumab: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
| Name | Gantenerumab |
| Summary | Page for Gantenerumab |
Knowledge base pages for this entity
flowchart TD
N0["Gantenerumab"]
N1["ALZHEIMER'S DISEASE"]
N1 -->|"associated with"| N0
N2["ADUCANUMAB"]
N0 -->|"associated with"| N2
N3["LECANEMAB"]
N0 -->|"associated with"| N3
N4["DONANEMAB"]
N0 -->|"associated with"| N4
N5["SOLANEZUMAB"]
N0 -->|"associated with"| N5
N6["CRENEZUMAB"]
N0 -->|"associated with"| N6
N7["AMYLOID"]
N0 -->|"associated with"| N7
N8["TAU"]
N0 -->|"associated with"| N8
classDef gene fill:#1a3a2a,stroke:#4caf50,color:#e0e0e0
classDef protein fill:#1a2a3a,stroke:#4fc3f7,color:#e0e0e0
classDef disease fill:#3a1a1a,stroke:#ef5350,color:#e0e0e0
classDef pathway fill:#2a1a3a,stroke:#ce93d8,color:#e0e0e0
classDef mechanism fill:#2a2a1a,stroke:#ffd54f,color:#e0e0e0
classDef drug fill:#1a2a2a,stroke:#26c6da,color:#e0e0e0
classDef cell_type fill:#2a1a2a,stroke:#ab47bc,color:#e0e0e0
classDef phenotype fill:#2a2a1a,stroke:#ffa726,color:#e0e0e0
classDef process fill:#1a2a2a,stroke:#66bb6a,color:#e0e0e0
classDef biological_process fill:#1a2a2a,stroke:#66bb6a,color:#e0e0e0
classDef concept fill:#1a1a2a,stroke:#7986cb,color:#e0e0e0
classDef entity fill:#1a2a3a,stroke:#4fc3f7,color:#e0e0e0
classDef therapeutic fill:#1a2a2a,stroke:#26c6da,color:#e0e0e0
classDef index fill:#1a1a2a,stroke:#7986cb,color:#e0e0e0
class N0 therapeutic
class N1 disease
class N2 drug
class N3 drug
class N4 drug
class N5 drug
class N6 drug
class N7 protein
class N8 protein| Target | Relation | Type | Str |
|---|---|---|---|
| SOLANEZUMAB | associated_with | drug | 0.45 |
| CRENEZUMAB | associated_with | drug | 0.45 |
| TAU | associated_with | protein | 0.45 |
| ADUCANUMAB | associated_with | drug | 0.45 |
| LECANEMAB | associated_with | drug | 0.45 |
| DONANEMAB | associated_with | drug | 0.45 |
| AMYLOID | associated_with | protein | 0.45 |
| ad_clinical_trial_failures:gantenerumab | data_in | dataset_row | 0.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ALZHEIMER'S DISEASE | associated_with | disease | 0.45 |
| ad_clinical_trial_failures:gantenerumab | data_in | dataset_row | 0.00 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||